143
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Long-term safety and analgesic efficacy of buprenorphine buccal film in patients with moderate-to-severe chronic pain requiring around-the-clock opioids

, , , &
Pages 233-240 | Published online: 25 Jan 2017

References

  • JohannesCBLeTKZhouXJohnstonJADworkinRHThe prevalence of chronic pain in United States adults: results of an Internet-based surveyJ Pain201011111230123920797916
  • GaskinDJRichardPThe economic costs of pain in the United StatesJ Pain201213871572422607834
  • ChouRFanciulloGJFinePGClinical guidelines for the use of chronic opioid therapy in chronic noncancer painJ Pain200910211313019187889
  • DowellDHaegerichTMChouRCDC Guideline for prescribing opioids for chronic pain – United States, 2016MMWR Recomm Rep2016651149
  • BenyaminRTrescotAMDattaSOpioid complications and side effectsPain Physician2008112 SupplS105S12018443635
  • ManchikantiLDamronKSMcManusCDBarnhillRCPatterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: a prospective, observational studyPain Physician20047443143716858484
  • PalmerRECarrellDSCronkiteDThe prevalence of problem opioid use in patients receiving chronic opioid therapy: computer-assisted review of electronic health record clinical notesPain201515671208121425760471
  • VowlesKEMcEnteeMLJulnesPSFroheTNeyJPvan der GoesDNRates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesisPain2015156456957625785523
  • ChristophTKogelBSchieneKMeenMDeVJFriderichsEBroad analgesic profile of buprenorphine in rodent models of acute and chronic painEur J Pharmacol20055071–3879815659298
  • WalshSLPrestonKLBigelowGEStitzerMLAcute administration of buprenorphine in humans: partial agonist and blockade effectsJ Pharmacol Exp Ther199527413613727542336
  • KoppertWIhmsenHKorberNDifferent profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain modelPain20051181–2152216154698
  • DavisMPTwelve reasons for considering buprenorphine as a frontline analgesic in the management of painJ Support Oncol201210620921922809652
  • SittlRLikarRNautrupBPEquipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort studyClin Ther200527222523715811486
  • ZakiPAKeithDEJrBrineGACarrollFIEvansCJLigand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?J Pharmacol Exp Ther200029231127113410688632
  • LutfyKCowanABuprenorphine: a unique drug with complex pharmacologyCurr Neuropharmacol20042439540218997874
  • Biodelivery Sciences InternationalTechnology platform2016 http://www.bdsi.com/Technology_Platforms.aspxAccessed April 1, 2016
  • Belbuca™ (buprenorphine) buccal film, CIII [package insert]Malvern, PAEndo Pharmaceuticals Inc2015
  • BaiSAXiangQFinnAEvaluation of the pharmacokinetics of single-and multiple-dose buprenorphine buccal film in healthy volunteersClin Ther201638235836926804639
  • RauckRLPottsJXiangQTzanisEFinnAEfficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back painPostgrad Med20161281111
  • GimbelJSpieringsELKatzNXiangQTzanisEFinnAEfficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal studyPain2016157112517252627434505
  • WessonDRLingWThe Clinical Opiate Withdrawal Scale (COWS)J Psychoactive Drugs200335225325912924748
  • MooreRAMcQuayHJPrevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioidsArthritis Res Ther200575R1046R105116207320
  • DahanAYassenABijlHComparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and ratsBr J Anaesth200594682583415833777
  • DahanAYassenARombergRBuprenorphine induces ceiling in respiratory depression but not in analgesiaBr J Anaesth200696562763216547090
  • PergolizziJAloisiAMDahanACurrent knowledge of buprenorphine and its unique pharmacological profilePain Pract201010542845020492579
  • WebsterLGruenerDKirbyTXiangQTzanisEFinnAEvaluation of the tolerability of switching patients on chronic full mu-opioid agonist therapy to buccal buprenorphinePain Med Epub225201610.1093/pm/pnv110
  • TompkinsDASmithMTMintzerMZCampbellCMStrainECA double-blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphineJ Pharmacol Exp Ther2014348221722624227768
  • FreyeEAnderson-HillemacherARitzdorfILevyJVOpioid rotation from high-dose morphine to transdermal buprenorphine (Transtec®) in chronic pain patientsPain Pract20077212312917559481
  • WolffRFAuneDTruyersCSystematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe painCurr Med Res Opin201228583384522443154